TILsWorkGroup's profile picture. We are interested in the immune infiltrate in Breast cancer and what it means for treatment and prevention.

TILs Working Group

@TILsWorkGroup

We are interested in the immune infiltrate in Breast cancer and what it means for treatment and prevention.

置顶

We've recently launched a global survey on the potential use of #TILs for future trial designs and use in daily practice. We would love to hear what you have to say 👇fd7.formdesk.com/BQA/TILs_TNBC_…


TILs Working Group 已转帖

Tagging @TILsWorkGroup to amplify this great work

✨✨hot off the press from the #loilab. We show here that pregnancy & breastfeeding is associated with increased T cells in the normal breast and protection against #tnbc #breastcancer moving the role of immunity from treatment to prevention. 👏👏Thanks to @FAndreMD @DrChoueiri



TILs Working Group 已转帖

✨✨hot off the press from the #loilab. We show here that pregnancy & breastfeeding is associated with increased T cells in the normal breast and protection against #tnbc #breastcancer moving the role of immunity from treatment to prevention. 👏👏Thanks to @FAndreMD @DrChoueiri

Translational data shows that #breastfeeding helps personal immunity improving CD8+ T This work can help to understand better the immune system and breastfeeding mechanisms @LoiSher @OncoAlert #ESMO25 @FernandoOnco

FernandoOnco's tweet image. Translational data shows that #breastfeeding helps personal immunity improving CD8+ T 
This work can help to understand better the immune system and breastfeeding mechanisms @LoiSher @OncoAlert #ESMO25 @FernandoOnco


The EU-funded MSCA Doctoral Network “Spatial Crosstalk in Immune-Oncology” (SpaXio) is now officially recruiting 14 PhD students to decipher the metastasis-promoting microenvironment of colon and breast cancer. More info here: tilsinbreastcancer.org/wp-content/upl…


TILs Working Group 已转帖

😎if #TIL had been the prespecified biomarker, pembrolizumab might well be approved for this indication. PD-L1 IHC has real technical limitations- patients deserve multiple validated ways to identified immune enriched tumors. #TILs are simple, free & readily available- wait 🤔is…

💫🌟Association of potential biomarkers with clinical outcomes in metastatic TNBC treated with pembrolizumab or chemotherapy 👉 nature.com/articles/s4152… @JavierCortesMD @ProfAnthoG @ASCOPres @Prof_Nadia_H @LoiSher 🧬 KEYNOTE-119 exploratory biomarker analysis 🔹 TILs ≥5% → ↑…

MedicalwatchHQ's tweet image. 💫🌟Association of potential biomarkers with clinical outcomes in metastatic TNBC treated with pembrolizumab or chemotherapy
👉 nature.com/articles/s4152…
@JavierCortesMD @ProfAnthoG @ASCOPres @Prof_Nadia_H @LoiSher
🧬 KEYNOTE-119 exploratory biomarker analysis

🔹 TILs ≥5% → ↑…


Study across 45 institutions shows AI validity in TIL quantification for melanoma. Reproducible with prognostic validity and open-source. @tznaung 👉 jamanetwork.com/journals/jaman… #AIinPathology #Melanoma #ComputationalPathology


TILs Working Group 已转帖

Some studies shows how we can reduce costs based on biomarkers SHORT-HER 9 weeks of trastuzumab is ✅ based TILS 20% or more @TILsWorkGroup @OncoAlert #oncoalertAF @JAMAOnc⤵️ jamanetwork.com/journals/jamao…


TILs Working Group 已转帖

Great slide highlighting not only are TILs predictive of pCR...it also translates to being prognostic beyond pCR for good outcome and DFS. Seems like we have a LOT of data on TILs now, why aren't they standardly provided on path reports???🧐 #SABCS24 @SABCSSanAntonio @OncoAlert

ErikaHamilton9's tweet image. Great slide highlighting not only are TILs predictive of pCR...it also translates to being prognostic beyond pCR for good outcome and DFS.

Seems like we have a LOT of data on TILs now, why aren't they standardly provided on path reports???🧐

#SABCS24
@SABCSSanAntonio
@OncoAlert

🤩🍾10th anniversary TILs-Working Group at @SABCSSanAntonio 2024 - everyone welcome! RSVP here: forms.office.com/Pages/Response…

TILsWorkGroup's tweet image. 🤩🍾10th anniversary TILs-Working Group at @SABCSSanAntonio 2024 - everyone welcome! RSVP here: forms.office.com/Pages/Response…

The largest TILs-Workshop done so far! More than 100 pathologist, residents in training and medical students learning how to score TILs. Organized by the Narayana Medical College, India. Who follows? 💪🏼

TILsWorkGroup's tweet image. The largest TILs-Workshop done so far! More than 100 pathologist, residents in training and medical students learning how to score TILs. Organized by the Narayana Medical College, India. Who follows? 💪🏼
TILsWorkGroup's tweet image. The largest TILs-Workshop done so far! More than 100 pathologist, residents in training and medical students learning how to score TILs. Organized by the Narayana Medical College, India. Who follows? 💪🏼
TILsWorkGroup's tweet image. The largest TILs-Workshop done so far! More than 100 pathologist, residents in training and medical students learning how to score TILs. Organized by the Narayana Medical College, India. Who follows? 💪🏼

🤩Check out latest article in @NatureRevCancer! #TILsInBreastCancer #Researchpaper

Towards targeting the breast cancer immune microenvironment dlvr.it/T9C7GF



TILs Working Group 已转帖

Our latest review is out now on targeting #BreastCancer #Immunity #tme #trm #CancerResearch many thanks to @NatureRevCancer @PeterMacCC @PeterMacRes @TILsWorkGroup

Towards targeting the breast cancer immune microenvironment dlvr.it/T9C7GF



Sharing a new breast cancer-focused funding opportunity: AACR-AstraZeneca Breast Cancer Research Fellowship for Endocrine Therapy Research. USD130,000 (2yrs). Closes 15th Aug 24. More details 👇 aacr.org/grants/aacr-as…


Pathologists in >166 countries consulted the TILs-website. Don’t stay behind! 🗺️ #TILs tilsinbreastcancer.org

TILsWorkGroup's tweet image. Pathologists in >166 countries consulted the TILs-website. Don’t stay behind! 🗺️ #TILs tilsinbreastcancer.org

A global effort by the TILs-WG published in @JAMA_current , one of the 🔝 medical journals worldwide #TILs 👉🏼 jamanetwork.com/journals/jama/…

jamanetwork.com

Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer

This study of patients with early-stage triple-negative breast cancer not treated with adjuvant or neoadjuvant chemotherapy analyzes the association between tumor-infiltrating lymphocyte levels,...

In patients with early-stage triple-negative breast cancer treated with locoregional therapy only, higher levels of tumor-infiltrating lymphocytes in breast cancer tissue were associated with improved survival. ja.ma/4aCzMeD

JAMA_current's tweet image. In patients with early-stage triple-negative breast cancer treated with locoregional therapy only, higher levels of tumor-infiltrating lymphocytes in breast cancer tissue were associated with improved survival. 

ja.ma/4aCzMeD


Loading...

Something went wrong.


Something went wrong.